Home > News > Zyvex Continues to Exceed Sales Expectations
January 26th, 2005
Zyvex Continues to Exceed Sales Expectations
Zyvex today announced financial results for its fiscal 2004 fourth quarter. The Texas company continues its business gains with nine consecutive quarters of sales growth and expansion of its global sales reach.
Total revenue for the fourth quarter was $4.0 million, which was a 55 percent increase over the same period in 2003.
The total revenue for 2004 was $8.6 million, which represented a 102 percent increase over 2003. International sales, new to the company during 2004, accounted for 10 percent of the year’s revenue.
UT Arlington physicist creates new nanoparticle for cancer therapy April 16th, 2014
Relieving electric vehicle range anxiety with improved batteries: Lithium-sulfur batteries last longer with nanomaterial-packed cathode April 16th, 2014
Aerotech X-Y ball-screw stage for economical high performance Planar positioning April 16th, 2014
Energy Research Facility Construction Project at Brookhaven Lab Wins U.S. Energy Secretary's Achievement Award April 16th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Acid folic was used in the production of the nanogel as targeting agent in drug delivery. The nanogel can be used in the treatment of cancer as a stable nanocarrier. Stability of nanocarriers is an important issue in target delivery mechanisms. Most of nanocarriers, due to their March 17th, 2014
Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014
Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014